SMAD2 and ovarian carcinoma: We then transiently overexpressed Smad2 and Smad3 in ovarian cancer cells, CAOV3 and SKOV3, respectively, and found that only the overexpression of Smad2 increased the mRNA levels of USP9X (Supplementary Fig. S1R).